Richard L. Love, Director at CELL THERAPEUTICS INC (CTIC), sold 75,000 shares at $0.37 ($28K) on 2010-08-23, disclosed to the SEC on 2010-08-25.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.37 | 4,502 | $2K | 6.0% |
| 2 | $0.37 | 7,400 | $3K | 9.9% |
| 3 | $0.37 | 8,515 | $3K | 11.3% |
| 4 | $0.37 | 21,389 | $8K | 28.5% |
| 5 | $0.37 | 30,094 | $11K | 40.1% |
| 6 | $0.38 | 3,100 |
| $1K |
| 4.2% |
| Total | $0.37 avg | 75,000 | $28K | 100% |
| Filing → |
| PRXL | SELL | 2015-12-02 | $91K | — | Filing → |
| CTIC | SELL | 2015-10-01 | $20K | — | Filing → |
| PRXL | SELL | 2015-09-03 | $85K | — | Filing → |